MDB Capital Holdings, LLC (NASDAQ:MDBH) Short Interest Update

MDB Capital Holdings, LLC (NASDAQ:MDBH) was the recipient of a significant increase in short interest in March. As of March 13th, there was short interest totaling 6,192 shares, an increase of 463.4% from the February 26th total of 1,099 shares. Approximately 0.1% of the company’s stock are sold short. Based on an average daily trading volume, of 8,191 shares, the short-interest ratio is currently 0.8 days. Based on an average daily trading volume, of 8,191 shares, the short-interest ratio is currently 0.8 days. Approximately 0.1% of the company’s stock are sold short.

MDB Capital Stock Performance

Shares of MDBH stock traded up $0.07 during mid-day trading on Tuesday, hitting $2.95. The company’s stock had a trading volume of 5,299 shares, compared to its average volume of 5,974. The stock has a market cap of $29.91 million, a price-to-earnings ratio of 3.17 and a beta of 1.05. MDB Capital has a 52-week low of $2.75 and a 52-week high of $6.52. The business has a 50-day moving average price of $3.16 and a 200 day moving average price of $3.42.

Hedge Funds Weigh In On MDB Capital

A number of hedge funds have recently bought and sold shares of the business. Raymond James Financial Inc. purchased a new stake in shares of MDB Capital during the 2nd quarter valued at about $27,000. Citadel Advisors LLC purchased a new position in shares of MDB Capital in the third quarter worth approximately $43,000. Finally, DRW Securities LLC bought a new stake in MDB Capital during the fourth quarter valued at approximately $40,000. Hedge funds and other institutional investors own 0.35% of the company’s stock.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of MDB Capital in a report on Thursday, January 22nd. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of “Sell”.

MDB Capital Company Profile

MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business.